USA Constipation Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing is termed as constipation. Constipation may be occasional which lasts for few weeks or may be chronic which lasts for longer period and is recurrent. It may be associated with other conditions such as irritable bowel syndrome or opioid consumption.

    Based on disease type, the global constipation treatment market is segmented into chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C) and opioid induced constipation (OIC). High prevalence of chronic constipation is estimated to contribute for dominating share of CIC segment in global market while increasing opioid consumption is projected to propel for exponential growth of OIC segment during forecast period.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Constipation market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Constipation market. Detailed analysis of key players, along with key growth strategies adopted by Constipation industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Takeda Pharmaceuticals Company Limited

    • Renexxion, LLC

    • Janssen Pharmaceutical Company

    • Synergy Pharmaceuticals, Inc

    • AstraZeneca

    • Ltd, Albireo Pharma, Inc

    • Abbott Laboratories

    • Valeant Pharmaceuticals International, Inc

    • Bayer AG

    • Shionogi & Co

    • Sucampo Pharmaceuticals, Inc

    • Prestige Brands Holdings, Inc

    • Daewoong Pharmaceuticals Co Ltd

    • Cosmo Pharmaceuticals NV

    • Ironwood Pharmaceuticals, Inc

    • Sanofi

    By Type:

    • Chronic Idiopathic Constipation (CIC)

    • Irritable Bowel Syndrome with Constipation (IBS-C)

    • Opioid-induced Constipation (OIC)

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Constipation Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Constipation Market Size and Growth Rate of Chronic Idiopathic Constipation (CIC) from 2016 to 2027

      • 1.3.2 USA Constipation Market Size and Growth Rate of Irritable Bowel Syndrome with Constipation (IBS-C) from 2016 to 2027

      • 1.3.3 USA Constipation Market Size and Growth Rate of Opioid-induced Constipation (OIC) from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Constipation Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027

      • 1.4.2 USA Constipation Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

      • 1.4.3 USA Constipation Market Size and Growth Rate of Online Pharmacies from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Constipation Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Constipation Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Constipation Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Constipation Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Constipation Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Constipation by Major Types

      • 3.4.1 Market Size and Growth Rate of Chronic Idiopathic Constipation (CIC)

      • 3.4.2 Market Size and Growth Rate of Irritable Bowel Syndrome with Constipation (IBS-C)

      • 3.4.3 Market Size and Growth Rate of Opioid-induced Constipation (OIC)

    4 Segmentation of Constipation Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Constipation by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Constipation in Hospital Pharmacies

      • 4.4.2 Market Size and Growth Rate of Constipation in Retail Pharmacies

      • 4.4.3 Market Size and Growth Rate of Constipation in Online Pharmacies

    5 Market Analysis by Regions

    • 5.1 USA Constipation Production Analysis by Regions

    • 5.2 USA Constipation Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Constipation Landscape Analysis

    • 6.1 West USA Constipation Landscape Analysis by Major Types

    • 6.2 West USA Constipation Landscape Analysis by Major End-Users

    7 South USA Constipation Landscape Analysis

    • 7.1 South USA Constipation Landscape Analysis by Major Types

    • 7.2 South USA Constipation Landscape Analysis by Major End-Users

    8 Middle West USA Constipation Landscape Analysis

    • 8.1 Middle West USA Constipation Landscape Analysis by Major Types

    • 8.2 Middle West USA Constipation Landscape Analysis by Major End-Users

    9 Northeast USA Constipation Landscape Analysis

    • 9.1 Northeast USA Constipation Landscape Analysis by Major Types

    • 9.2 Northeast USA Constipation Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Takeda Pharmaceuticals Company Limited

        • 10.1.1 Takeda Pharmaceuticals Company Limited Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Renexxion, LLC

        • 10.2.1 Renexxion, LLC Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Janssen Pharmaceutical Company

        • 10.3.1 Janssen Pharmaceutical Company Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Synergy Pharmaceuticals, Inc

        • 10.4.1 Synergy Pharmaceuticals, Inc Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 AstraZeneca

        • 10.5.1 AstraZeneca Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Ltd, Albireo Pharma, Inc

        • 10.6.1 Ltd, Albireo Pharma, Inc Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Abbott Laboratories

        • 10.7.1 Abbott Laboratories Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Valeant Pharmaceuticals International, Inc

        • 10.8.1 Valeant Pharmaceuticals International, Inc Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Bayer AG

        • 10.9.1 Bayer AG Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Shionogi & Co

        • 10.10.1 Shionogi & Co Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Sucampo Pharmaceuticals, Inc

        • 10.11.1 Sucampo Pharmaceuticals, Inc Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Prestige Brands Holdings, Inc

        • 10.12.1 Prestige Brands Holdings, Inc Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Daewoong Pharmaceuticals Co Ltd

        • 10.13.1 Daewoong Pharmaceuticals Co Ltd Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 Cosmo Pharmaceuticals NV

        • 10.14.1 Cosmo Pharmaceuticals NV Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 Ironwood Pharmaceuticals, Inc

        • 10.15.1 Ironwood Pharmaceuticals, Inc Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

      • 10.16 Sanofi

        • 10.16.1 Sanofi Company Profile and Recent Development

        • 10.16.2 Market Performance

        • 10.16.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Constipation Market Size and Growth Rate of Chronic Idiopathic Constipation (CIC) from 2016 to 2027

    • Figure USA Constipation Market Size and Growth Rate of Irritable Bowel Syndrome with Constipation (IBS-C) from 2016 to 2027

    • Figure USA Constipation Market Size and Growth Rate of Opioid-induced Constipation (OIC) from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Constipation Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027

    • Figure USA Constipation Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

    • Figure USA Constipation Market Size and Growth Rate of Online Pharmacies from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Constipation Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Constipation Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Constipation Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Constipation Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Constipation Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Constipation

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Constipation by Different Types from 2016 to 2027

    • Table Consumption Share of Constipation by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Chronic Idiopathic Constipation (CIC)

    • Figure Market Size and Growth Rate of Irritable Bowel Syndrome with Constipation (IBS-C)

    • Figure Market Size and Growth Rate of Opioid-induced Constipation (OIC)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Constipation by Different End-Users from 2016 to 2027

    • Table Consumption Share of Constipation by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Table USA Constipation Production by Regions

    • Table USA Constipation Production Share by Regions

    • Figure USA Constipation Production Share by Regions in 2016

    • Figure USA Constipation Production Share by Regions in 2021

    • Figure USA Constipation Production Share by Regions in 2027

    • Table USA Constipation Consumption by Regions

    • Table USA Constipation Consumption Share by Regions

    • Figure USA Constipation Consumption Share by Regions in 2016

    • Figure USA Constipation Consumption Share by Regions in 2021

    • Figure USA Constipation Consumption Share by Regions in 2027

    • Table West USA Constipation Consumption by Types from 2016 to 2027

    • Table West USA Constipation Consumption Share by Types from 2016 to 2027

    • Figure West USA Constipation Consumption Share by Types in 2016

    • Figure West USA Constipation Consumption Share by Types in 2021

    • Figure West USA Constipation Consumption Share by Types in 2027

    • Table West USA Constipation Consumption by End-Users from 2016 to 2027

    • Table West USA Constipation Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Constipation Consumption Share by End-Users in 2016

    • Figure West USA Constipation Consumption Share by End-Users in 2021

    • Figure West USA Constipation Consumption Share by End-Users in 2027

    • Table South USA Constipation Consumption by Types from 2016 to 2027

    • Table South USA Constipation Consumption Share by Types from 2016 to 2027

    • Figure South USA Constipation Consumption Share by Types in 2016

    • Figure South USA Constipation Consumption Share by Types in 2021

    • Figure South USA Constipation Consumption Share by Types in 2027

    • Table South USA Constipation Consumption by End-Users from 2016 to 2027

    • Table South USA Constipation Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Constipation Consumption Share by End-Users in 2016

    • Figure South USA Constipation Consumption Share by End-Users in 2021

    • Figure South USA Constipation Consumption Share by End-Users in 2027

    • Table Middle West USA Constipation Consumption by Types from 2016 to 2027

    • Table Middle West USA Constipation Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Constipation Consumption Share by Types in 2016

    • Figure Middle West USA Constipation Consumption Share by Types in 2021

    • Figure Middle West USA Constipation Consumption Share by Types in 2027

    • Table Middle West USA Constipation Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Constipation Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Constipation Consumption Share by End-Users in 2016

    • Figure Middle West USA Constipation Consumption Share by End-Users in 2021

    • Figure Middle West USA Constipation Consumption Share by End-Users in 2027

    • Table Northeast USA Constipation Consumption by Types from 2016 to 2027

    • Table Northeast USA Constipation Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Constipation Consumption Share by Types in 2016

    • Figure Northeast USA Constipation Consumption Share by Types in 2021

    • Figure Northeast USA Constipation Consumption Share by Types in 2027

    • Table Northeast USA Constipation Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Constipation Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Constipation Consumption Share by End-Users in 2016

    • Figure Northeast USA Constipation Consumption Share by End-Users in 2021

    • Figure Northeast USA Constipation Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Takeda Pharmaceuticals Company Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceuticals Company Limited

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceuticals Company Limited

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceuticals Company Limited

    • Table Product and Service Introduction of Takeda Pharmaceuticals Company Limited

    • Table Company Profile and Development Status of Renexxion, LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Renexxion, LLC

    • Figure Sales and Growth Rate Analysis of Renexxion, LLC

    • Figure Revenue and Market Share Analysis of Renexxion, LLC

    • Table Product and Service Introduction of Renexxion, LLC

    • Table Company Profile and Development Status of Janssen Pharmaceutical Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Pharmaceutical Company

    • Figure Sales and Growth Rate Analysis of Janssen Pharmaceutical Company

    • Figure Revenue and Market Share Analysis of Janssen Pharmaceutical Company

    • Table Product and Service Introduction of Janssen Pharmaceutical Company

    • Table Company Profile and Development Status of Synergy Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synergy Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Synergy Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Synergy Pharmaceuticals, Inc

    • Table Product and Service Introduction of Synergy Pharmaceuticals, Inc

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Ltd, Albireo Pharma, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ltd, Albireo Pharma, Inc

    • Figure Sales and Growth Rate Analysis of Ltd, Albireo Pharma, Inc

    • Figure Revenue and Market Share Analysis of Ltd, Albireo Pharma, Inc

    • Table Product and Service Introduction of Ltd, Albireo Pharma, Inc

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Valeant Pharmaceuticals International, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals International, Inc

    • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals International, Inc

    • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals International, Inc

    • Table Product and Service Introduction of Valeant Pharmaceuticals International, Inc

    • Table Company Profile and Development Status of Bayer AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

    • Figure Sales and Growth Rate Analysis of Bayer AG

    • Figure Revenue and Market Share Analysis of Bayer AG

    • Table Product and Service Introduction of Bayer AG

    • Table Company Profile and Development Status of Shionogi & Co

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi & Co

    • Figure Sales and Growth Rate Analysis of Shionogi & Co

    • Figure Revenue and Market Share Analysis of Shionogi & Co

    • Table Product and Service Introduction of Shionogi & Co

    • Table Company Profile and Development Status of Sucampo Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sucampo Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Sucampo Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Sucampo Pharmaceuticals, Inc

    • Table Product and Service Introduction of Sucampo Pharmaceuticals, Inc

    • Table Company Profile and Development Status of Prestige Brands Holdings, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Prestige Brands Holdings, Inc

    • Figure Sales and Growth Rate Analysis of Prestige Brands Holdings, Inc

    • Figure Revenue and Market Share Analysis of Prestige Brands Holdings, Inc

    • Table Product and Service Introduction of Prestige Brands Holdings, Inc

    • Table Company Profile and Development Status of Daewoong Pharmaceuticals Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daewoong Pharmaceuticals Co Ltd

    • Figure Sales and Growth Rate Analysis of Daewoong Pharmaceuticals Co Ltd

    • Figure Revenue and Market Share Analysis of Daewoong Pharmaceuticals Co Ltd

    • Table Product and Service Introduction of Daewoong Pharmaceuticals Co Ltd

    • Table Company Profile and Development Status of Cosmo Pharmaceuticals NV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cosmo Pharmaceuticals NV

    • Figure Sales and Growth Rate Analysis of Cosmo Pharmaceuticals NV

    • Figure Revenue and Market Share Analysis of Cosmo Pharmaceuticals NV

    • Table Product and Service Introduction of Cosmo Pharmaceuticals NV

    • Table Company Profile and Development Status of Ironwood Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Ironwood Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Ironwood Pharmaceuticals, Inc

    • Table Product and Service Introduction of Ironwood Pharmaceuticals, Inc

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.